Carmignac Gestion Elanco Animal Health Inc Transaction History

Carmignac Gestion

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$16.68 - $32.25 $45.1 Million - $87.3 Million	-2,705,856 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$25.29 - $29.45 $54.7 Million - $63.7 Million	-2,163,309 Reduced 44.43%	2,705,856 $79.7 Million
Q3 2019 Nov 13, 2019	SELL	$25.62 - $34.96 $22.7 Million - $31 Million	-887,620 Reduced 15.42%	4,869,165 $129 Million
Q2 2019 Aug 13, 2019	SELL	$31.11 - $34.79 $1.06 Million - $1.19 Million	-34,135 Reduced 0.59%	5,756,785 $195 Million
Q1 2019 May 14, 2019	BUY	$29.0 - $32.83 $137 Million - $156 Million	4,737,571 Added 449.76%	5,790,920 $186 Million
Q4 2018 Feb 13, 2019	BUY	$29.63 - $34.5 $23.2 Million - $27 Million	781,449 Added 287.4%	1,053,349 $88.6 Million
Q3 2018 Nov 13, 2018	BUY	$34.1 - $36.19 $9.27 Million - $9.84 Million	271,900 New	271,900 $9.49 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $5.56B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.